Use of the CDR® plus NACC FTLD in mild FTLD: Data from the ARTFL/LEFFTDS consortium.

MLA

Miyagawa, Toji, et al. “Use of the CDR® plus NACC FTLD in Mild FTLD: Data from the ARTFL/LEFFTDS Consortium.” Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, vol. 16, no. 1, Jan. 2020, pp. 79–90. EBSCOhost, https://doi.org/10.1016/j.jalz.2019.05.013.

APA

Miyagawa, T., Brushaber, D., Syrjanen, J., Kremers, W., Fields, J., Forsberg, L. K., Heuer, H. W., Knopman, D., Kornak, J., Boxer, A., Rosen, H., & Boeve, B. (2020). Use of the CDR® plus NACC FTLD in mild FTLD: Data from the ARTFL/LEFFTDS consortium. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 16(1), 79–90. https://doi.org/10.1016/j.jalz.2019.05.013

Chicago

Miyagawa, Toji, Danielle Brushaber, Jeremy Syrjanen, Walter Kremers, Julie Fields, Leah K. Forsberg, Hilary W. Heuer, et al. 2020. “Use of the CDR® plus NACC FTLD in Mild FTLD: Data from the ARTFL/LEFFTDS Consortium.” Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association 16 (1): 79–90. doi:10.1016/j.jalz.2019.05.013.